tiprankstipranks
Trending News
More News >
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market

CG Oncology, Inc. (CGON) Financial Statements

Compare
289 Followers

CG Oncology, Inc. Financial Overview

CG Oncology, Inc.'s market cap is currently $4.48B. The company's EPS TTM is $-0.57; its P/E ratio is -26.75; CG Oncology, Inc. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.14M$ 204.00K$ 191.00K$ 10.36M
Gross Profit$ 1.14M$ 204.00K$ 176.00K$ 10.35M
Operating Income$ -114.67M$ -55.45M$ -35.25M$ -12.61M
EBITDA$ -114.63M$ -55.43M$ -35.23M$ -12.38M
Net Income$ -88.04M$ -48.61M$ -35.44M$ -12.84M
Balance Sheet
Cash & Short-Term Investments$ 742.00M$ 187.67M$ 143.48M$ 53.61M
Total Assets$ 754.80M$ 199.30M$ 147.75M$ 58.69M
Total Debt$ 238.00K$ 1.03M$ 15.94M$ 15.13M
Net Debt$ -256.83M$ -7.24M$ -72.20M$ -38.48M
Total Liabilities$ 21.42M$ 14.51M$ 22.57M$ 18.44M
Stockholders' Equity$ 733.38M$ 184.79M$ 125.18M$ 40.25M
Cash Flow
Free Cash Flow$ -78.95M$ -45.68M$ -29.82M$ -13.75M
Operating Cash Flow$ -78.71M$ -45.68M$ -29.80M$ -13.65M
Investing Cash Flow$ -300.76M$ -121.19M$ -55.35M$ -97.00K
Financing Cash Flow$ 628.28M$ 87.00M$ 119.69M$ 15.45M
Currency in USD

CG Oncology, Inc. Earnings and Revenue History

CG Oncology, Inc. Debt to Assets

CG Oncology, Inc. Cash Flow

CG Oncology, Inc. Forecast EPS vs Actual EPS